Update on diagnosis and treatment of immune thrombocytopenia.
Rajeev SandalKundan MishraAditya JandialKamal Kant SahuAhmad Daniyal SiddiquiPublished in: Expert review of clinical pharmacology (2021)
We believe that more detailed studies are required to understand the exact pathophysiology behind ITP. The first-line drugs like corticosteroids have both short-term and long-term adverse effects. This brings the need to explore effective alternative medications and to reconsider their role in ITP treatment algorithm if guidelines can be modified based on new studies.